Sandeep Chidambar Kulkarni is CEO of Talaris Therapeutics, Inc.. Currently has a direct ownership of 729,735 shares of TALS, which is worth approximately $1.98 Million. The most recent transaction as insider was on Nov 17, 2023, when has been sold 4,000 shares (Common Stock) at a price of $16.99 per share, resulting in proceeds of $67,960. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 730K
0% 3M change
0% 12M change
Total Value Held $1.98 Million

Sandeep Chidambar Kulkarni Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 17 2023
BUY
Open market or private purchase
$67,960 $16.99 p/Share
4,000 Added 0.55%
729,735 Common Stock
Oct 26 2023
BUY
Open market or private purchase
$61,250 $12.25 p/Share
5,000 Added 0.68%
725,735 Common Stock
Oct 24 2023
BUY
Open market or private purchase
$49,662 $10.68 p/Share
4,650 Added 0.64%
720,735 Common Stock
Oct 19 2023
BUY
Grant, award, or other acquisition
-
716,085 Added 50.0%
716,085 Common Stock

Also insider at

JATT-WT
JATT Acquisition Corp
SCK

Sandeep Chidambar Kulkarni

CEO
La Jolla, CA

Track Institutional and Insider Activities on TALS

Follow Talaris Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TALS shares.

Notify only if

Insider Trading

Get notified when an Talaris Therapeutics, Inc. insider buys or sells TALS shares.

Notify only if

News

Receive news related to Talaris Therapeutics, Inc.

Track Activities on TALS